GE HealthCare granted FDA nod for Precision DL to process medical imaging
FinkAvenue

GE HealthCare (NASDAQ:GEHC) announced Tuesday that the FDA issued 510(k) clearance for Precision DL, a deep learning-based image processing software designed to enhance the quality of PET/CT imaging.
Precision DL, an AI-based technology, is available on GE HealthCare's (GEHC) PET/CT system Omni Legend.

It is the latest addition to the company's Effortless Recon DL portfolio, which leverages deep learning to improve image quality and enhance patient outcomes.
"One of the main advantages of moving fully into the future of AI and deep learning is making state-of-the-art imaging accessible to more practices, across more care areas than ever before," remarked Jan Makela, CEO of GEHC's imaging unit.
"Now we are proud to add Precision DL for PET/CT, enabling more precise and personalized care across healthcare systems' imaging departments."


More on GE HealthCare

GE HealthCare to benefit from updated NCCN breast cancer guidelines
GE HealthCare Technologies Is A Healthy Opportunity